2024-08-29 |
CMDUAMC2267478 |
RISING PHARMA HOLDINGS INC |
4818.0 kg |
300490
|
------------ TEMU9577196 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 24 PACKAGES 540 CARTONS ON 24 PACKAGES (FIVE HUNDRED FORTY CARTONS ON TWENTY FOUR PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATI PER ORDER NO.: 204969 (4500014144) 205022 (4500014506) 205039 (4500014686) 205048 (4500014728) OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS,15MG 100CT NDC 64980-211-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS,5MG 100CT NDC 64980-209-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 CARBAMAZEPINE EXTENDED RELEASE TABLETS 400MG,NDC 16571-682-01-HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 CUSTOMS INVOICE NO.: 1240625758 DT.24.07.2024 1240625759 DT.24.07.2024 COMMERCIAL INVOICE NO.: 90029136 DT.24.07.2024 90029137 DT.24.07.2024 NET WEIGHT : 3,472.010 KGS HIND CYCLE ROAD, WORLI, MUMBAI 400 030, INDI TEL: 30451397/259 MARCELLA.RODRIGUEZ SAVINODELBENE.COM RISINGPHARMA.NY SAVINODELBENE.COM CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WI MASTER BILLS NO AMC2248906 FREIGHT COLLECT -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER S THE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |
2024-07-30 |
SULPTHN008555NYC |
RISING PHARMA HOLDINGS INC |
6764.0 kg |
300490
|
779 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO204967 4500014142 2050384500014683 2049974500014324 205018 4500014502 GLIPIZIDE EXTENDED RLEASE TABLETS 2.5MG NDC: 6498027903 HTS CODE:3004909190 HS CODE 3004 90 99 MIDODRINE HYDR OCHLORIDE TABLETS USP 5MG 100 CT NDC: 6498043 401 HTS CODE: 3004909220 HS CODE NO3004 90 99CUSTOMS INVOICE NO: 1240625496 DT 18.06.2024 1240625500 DT 18.06.2024 COMMERCIAL INVOICE NO: 90028909 DT . 18.06.2024 SB NO:1761975 DT. 18.06.2024, 1761998 DT.18.06.2024 NET WT 4383.400 |
2024-07-30 |
SULPTHN008553NYC |
RISING PHARMA HOLDINGS INC |
6232.0 kg |
300490
|
621 CARTONS ON 35 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 205051 4500014860 205018 4500014502 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 1657140250 HTS 3004.90.9180 HS CODE NO.: 3004 9031 GLIPIZIDE EXTENDED RELEASE TABLETS 10MG 1 00CT NDC 6498028101 HTS CODE 3004.90.9190 HS CODE : 3004 90 99 GLIPIZIDE EXTENDED RELEASE TABLETS 5MG 100CT NDC 6498028001 HTS CODE 3004.90.9190 HS CODE : 3004 90 99 SB NO: DT. NETWT.:4462.670 KGS |
2024-07-30 |
SULPTHN008552NYC |
RISING PHARMA HOLDINGS INC |
5804.0 kg |
300490
|
800 CARTONS ON 35 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO: 205030 4500014698 205042 4500014679 205040 4500014684 205032 4500014677 204969 4500014144 205000 4500014327 204949 4500012841 205031 4500014704 205032 4500014677 BLUE POINT- DICLOFENAC SODIUM DELAYED-RELEASE TABLETS USP 25M G 100CT NDC 68001-279-00- HTS 3004.90.9120 HSCODE : 3004 90 69 DICLOFENAC SODIUM DELAYED- RELEASE TABLETS, USP 25MG 100CT NDC 16571-20 3-10- HTS 3004.90.9120 HS CODE : 3004 90 69 TINIDAZOLE TABLETS 500MG 12CT NDC 64980-427-12- HTS 3004.90.9110 HS CODE NO.: 3004 90 23 C ARBAMAZEPINE EXTENDED RELEASE TABLETS 100MG,00 CT NDC 16571-680-01- HTS CODE 3004.90.9230 HS CODE NO.:004 90 81 OXYBUTYNIN CHLORIDE EXTENDED- ELEASE TABLETS, USP 5MG 100CT NDC 64980-209-1 HTS 3004.90.9190 HS CODE : 3004 90 99CLOTRIMAZOLE TROCHE LOZENGE 10 MG 70CT NDC 1 657168607 HS CODE : 3004 90 99 CLOTRIMAZOLE TROCHE LOZENGE 10 MG 70CT NDC 1657168614 HS CODE : 3004 90 99 BLUE POINT- MLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25 MG 100 CT NDC 680015 2900 HTS 3004.90.9280 HS CODE : 3004 90 39 CARBAMAZEPINE EXTENDED RELEASE TABLETS 200MG 100 ACT NDC 1657168101 HTS CODE 3004.90.9230 HSCODE NO.: 3004 90 81 SB NO: DT. NET WT.:4094 .120 KGS |
2024-07-30 |
SULPTHN008556NYC |
RISING PHARMA HOLDINGS INC |
7001.0 kg |
300490
|
875 CARTONS ON 38 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 205047 4500014727 205051 4500014860 2050424500014679 205030 4500014698 205033 45000146 78 205041 4500014685 205034 4500014680 2050384500014683 205031 4500014704 205037 45000146 82 LORATADINE TABLETS USP 10 MG 300CT NDC 165 71-0822-30 - HTS CODE 3004.90.9280 HS CODE NO.: 3004 90 39 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 16571-402-50 - HTS 3004.90.9180 HS CODE NO.: 3004 90 31 DICLOFENAC SODIUMDELAYED-RELEASE TABLETS, USP 50MG 1,000CT ND C 16571-202-11 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 50MG 60CT - NDC 6 8001-280-06 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 50MG 100CT - NDC 68001-280-00 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 50MG 1,000CT - NDC 68001-280-08 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CLOMIPRAMINE CAPS 75MG 30CT NDC 16571 -068-503-HTS 3004.90.9235 HS CODE NO.: 3004 90 99 CLOMIPRAMINE CAPS 75MG 90CT NDC 16571-068-509-HTS 3004.90.9235 HS CODE NO.: 3004 90 99 TOLTERODINE TARTRATE TAB 2 MG 60 CT NDC 16571-127-06- HTS 3004.90.9265 HS CODE NO.: 300490 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 10M G 500CT NDC 64980-281-05 - HTS CODE 3004.90.9190 HS CODE : 3004 90 99 MIDODRINE HYDROCHLOR IDE TABLETS, USP 2.5MG 100 CT NDC 64980-433-01 - HTS CODE 3004.90.9220 HS CODE NO.: 3004 90 99 BLUE POINT - MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25 MG 1000 CT NDC 68001-529-08 - HTS 3004.90.9280 HS CODE : 3004 90 39 MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25MG 100CT-NDC 16571-824-01-HTS 3004.90.9280 HS CODE :3004 90 39 CUSTOMS INVOICE NO.: 1240625497 D T.18.06.2024 1240625498 DT.18.06.2024 1240625502 DT.18.06.2024 COMMERCIAL INVOICE NO.: 90028910 DT.18.06.2024 SB NO: 1764178 DT.18.06.2024 1764173 DT.18.06.2024 1764180 DT.18.06.2024 NET WT.: 4997.240 KGS |
2024-07-14 |
OOLU230274523001 |
RISING PHARMA HOLDINGS INC |
6962.0 kg |
310510
|
GLIPIZIDE EXTENDED-RELEASE TABLETS 10MG 500CT |
2024-07-04 |
OOLU230256144001 |
RISING PHARMA HOLDINGS INC |
7774.0 kg |
310510
|
CIPROFLOXACIN TABLETS, GLIPIZIDE EXTENDED-RELEASE TABLETS , |
2024-07-04 |
OOLU230273891001 |
RISING PHARMA HOLDINGS INC |
4905.0 kg |
310510
|
CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT,ATENOLOL TABLETS |
2024-06-26 |
OOLU230256143001 |
RISING PHARMA HOLDINGS INC |
6461.0 kg |
310420
|
OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS |
2024-06-17 |
MEDUFS287011 |
RISING PHARMA HOLDINGS INC |
6790.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 1405 CARTONS ON 4 0 PACKAGES (ONE THOUSAND FOUR HUNDREDFIVE CARTONS ON FORTY PACKAGES ONLY) SHIPMEN T OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204935 (4 500013873) 204953 (4 500014 103) 204965 (4500014140) 2 05025 (4500014524) 204996 (4500014323) CETIRIZINE H YDRO CHLORIDE TABLETS 5MG 1 00CT NDC 16571-401-10 - HTS 3004.90.9180 HS CODE : 3004 90 69 DICLOFENAC SO DIUM DELAYED-RELEASE TABLE TS, USP 75MG 1,000CT NDC 1 6571-201-11 - HTS 3004.90. 9120 HS CODE : 3004 90 69 DICLOFENAC SODIUM DELAYED -RELEASE TABLETS, USP 75MG 100CT NDC 16571-201-10 - HTS 3004.90.9120 HS CODE : 300490 69 CUSTOMS INV OICE NO.: 1240625153 DT.2 9.04.2024 COMMERCIAL INVOI CE NO.: 90028623 DT.30.0 4.2024 SB NO: 9501463 DT. 29.04.2024 NET. WT. 4,685. 460 KGS THE TEMPERATURE TO BE SET AT +18 DEGREE CELC IUS IN ACCORDANCE WITHSHI PPER INSTRUCTIONS |
2024-06-17 |
MEDUFS287052 |
RISING PHARMA HOLDINGS INC |
7223.0 kg |
300420
|
1 X 40FT HC RF CONTAINER C ONTAINS 1209 CARTONS ON 42 PALLETS (ONE THOUSAND TWO HUNDRED NINE CARTONS O N FORTY TWO PACKAGES ONLY) SHIPMENT OF PHARMACEUT ICAL FINISHED FORMULATION AS PER ORDER NO.: 204 995 (4500014322) 205001 (4500014328) 205021 (450 0014505) 205024 (4500014 523) 205020 (4500014504) 205023 (4500014 522) 2 04994 (4500014321) 20499 2 (4500014319) 204996 (4 500014323) 204945 (45000 13877) 205025 (450001452 4) CIPROFLOXACIN TABLETS , UPS 500MG 500CT NDC 1 6571-412-50 - HTS 3004.20. 0060 HS CODE : 3004 20 1 3 TOLTERODINE TARTRATE T AB 1 MG 60 CT NDC 16571- 126-06- HTS 3004.90.9265 HS CODE NO.: 3004 90 99 TOLTERODINE TARTRATE TAB 2 MG 60 CT NDC 16571-127 -06 - HTS 3004.90.9265 HS CODE NO.: 3004 90 99 MIDODRINE HYDROCHLORIDE TAB LETS, USP 5MG 100 CT NDC 64980-434-01 - HTS CODE 3004.90.9220 HS CODE NO. : 3004 90 99 BLUE POINT - DICLOFENAC SODIUM DELAYE D-RELEASE TABLETS, USP 50M G60CT - NDC 68001-280-06 - HTS 3004.90.9120 H S CO DE : 3004 90 69 BLUE POI NT - DICLOFENACSODIUM DEL AYED-RELEASE TABLETS, USP 50MG 10 0CT - NDC 68001-280 -00 - HTS 3004.90.9120 H S CODE : 3004 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 75MG 60CT - NDC 68001- 281-06 - HTS 3004.90.9120 HS CODE : 3004 90 69 B LUE POINT - DICLOFENAC SOD IUM DELAYED-RELEASE TABLET S, USP 75MG 100CT -NDC 68 001-281-00 - HTS 3004.90.9 120 HS COD E : 3004 90 69 MECLIZINE HYDROCHLORIDE CHEWAB LE TABLETS 25MG 100 CT-NDC 16571-824-01-HTS 30 04.90.9280 HS CODE : 300 4 90 39 BLUE POINT- MEC LIZINE HYDROCHLORIDE CHEWA BLE TABLETS 12.5 MG 100 C T NDC 68001-528-00 - HTS 3 004 .90.9280 HS CODE : 30 04 90 39 CARBAMAZEPINE E XTENDED RELEASE TABLETS 10 0MG,100 CT NDC 16571-680 -01-HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 DICLOFENAC SODIUM DELAYE D-RELE ASE TABLETS, USP 50M G 60CT NDC 16571-202-06 - HTS 3004.90.9120 HS C ODE : 3004 90 69 DICLOFE NAC SODIUM DELAYED-RELEASE TABLETS, USP 75MG 60CT NDC 16571-201-06 - HTS 3 004.90.9120HS CODE : 30 04 90 69 DICLOFENAC SODI UM DEL AYED-RELEASE TABLETS , USP 50MG 1,000CT NDC 16571-202-11 - HTS 3004.90. 9120 HS CODE : 30 04 90 6 9 CUSTOMS INVOICE NO.: 1240625148 DT. 29.04.2024 1 240625154 DT.29.04.2024 12 40625156 DT.29.04.2024 CO MMERCIAL INVOICE NO.: 900 28622 DT.30.04.2024 SB NO : 9501477 DT.29.04.2024 95 01481 DT.29.04.2024 950148 7 DT.29.04.2024 NET. WT. 5,135.350 KGS === MARCEL LA.RODRIGUEZ=SAVINODELBENE .COM RISINGPHARMA.NY=SAVIN ODELBENE.COM CONTACT NO.: +1-718-906-2732 THE TEMPE RATURE TO BE SET AT +18 DE GREE CELCIUS IN ACCORDANCE WITH SHIPPER INSTRUCTIONS |
2024-06-04 |
MEDUFS133025 |
RISING PHARMA HOLDINGS INC |
7981.0 kg |
300490
|
1X40 FT HC RF CONTAINER C ONTAINS 1080 CAR TONS ON 38 PACKAGES (ONE THOUSA ND EIGHTY CARTONS ON THIRT Y EIGHT PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION A S PER ORDER NO.: 20499 6 (4500014323) 204935 (4 500013873) 204996 (45000 14323) DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 75MG 60CT NDC 1657 1-201-06 - HTS 30 04.90.912 0 HS CODE : 3004 90 69 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 1657 1-402-50 - HTS 3004.90 .9180 HS CODE NO.: 3 004 90 31 NET WEIGHT : 5,817 .470 KGS GR OSS WEIGHT: 7,981.220 KGS CUSTOMS IN VOICE N O.: 1240625062 DT : 22.04.2024 COMMERCIAL INVOICE NO.: 90028550 D T: 22.04.2024 S .BILL NO : 9311492 DT.22.04.2024 FREIGTHT P REPAID TEMPE RATURE : +18 DEGREE CELS I US VENT. : CLOSED, HU MIDITY. : NA = WORLI, MUMBAI 400030, INDIA. TEL: 30451397/2 59 == MA IL I D MARCELLA.RODRIGUEZ= SAVINO DELBENE.COM RISINGPH ARMA.NY=SAVINODELBENE.COM CONTACT NO.: +1-718-906-27 32 THE TEMPERA TURE TO BE SET AT +18 DEGREE CELCIUS IN ACCOR DANCE WITH SHIPPE R INSTRUCTIONS |
2024-06-04 |
HLCUBO1ODBGRC0AA |
RISING PHARMA HOLDINGS INC |
7602.0 kg |
300490
|
SHIPMENT OF PHARMACEUTICAL 1 X 40FT HC RF CONTAINER CONTAINS TOTAL 39 PACKAGES 1273 CARTONS ON 39 PACKAGES (ONE THOUSAND TWO HUNDRED SEVENTY THREE CARTONS ON THIRTY NINE PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO. 204965 (4500014140) 205025 (4500014524) CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 16571-402-50 - HTS 3004.90.9180 HS CODE 3004 90 69 DICLOFENAC SODIUM DELAYED -RELEASE TABLETS, USP 75MG 60CT NDC 16571-201-06 - HTS 3004.90.9120 HS CODE 3004 90 69 DICLOFENAC SODIUM DELAYED- RELEASE TABLETS, USP 75MG 100CT NDC 16571-201-10 - HTS 3004.90.9120 HS CODE 3004 90 69 CUSTOMS INVOICE NO. 1240625217 DT.30.04.2024 COMMERCIAL INVOICE NO. 90028650 DT.30.04.2024 SB NO 9534234 DT.30.04.2024 NET WEIGHT 5,630.300 KGS FREIGHT PREPAID |
2024-06-04 |
HLCUBO1ODBGRA8AA |
RISING PHARMA HOLDINGS INC |
7519.0 kg |
300490
|
LITHIUM CARBONATE EXTENDED-RELEASE 1 X 40FT HC RF CONTAINER CONTAINS TOTAL 40 PACKAGES 835 CARTONS ON 40 PACKAGES (EIGHT HUNDRED THIRTY FIVE CARTONS ON FORTY PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO. 205019 (4500014503) 204955 (4500014105) 204967 (4500014142) 204948 (4500013972) 204997 (4500014324) 204967 (4500014142) LITHIUM CARBONATE EXTENDED -RELEASE TABLETS, USP 300MG 500CT NDC 64980-205-05 - HTS 3004.90.9135 HS CODE 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 100CT NDC 64980-280-01 - HTS CODE 3004.90.9190 HS CODE 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, USP 10MG 100CT NDC 64980-210-01 - HTS 3004.90.9190 HS CODE 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 500CT NDC 64980-280-05 - HTS CODE 3004.90.9190 HS CODE 3004 90 99 CUSTOMS INVOICE NO. 1240625223 DT.30.04.2024 1240625226 DT.30.04.2024 COMMERCIAL INVOICE NO. 90028651 DT.30.04.2024 90028652 DT.30.04.2024 SB NO 9543477 DT.01.05.2024 9543488 DT.01.05.2024 NET WEIGHT 5,339.760 KGS FREIGHT PREPAID |
2024-06-04 |
OOLU230234357001 |
RISING PHARMA HOLDINGS INC |
3602.0 kg |
292119
|
CETIRIZINE HYDROCHLORIDE,OXYBUTYNIN CHLORIDE, |
2024-06-04 |
OOLU230234358001 |
RISING PHARMA HOLDINGS INC |
8971.0 kg |
310510
|
GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 1,000CT |
2024-06-02 |
OOLU230221626001 |
RISING PHARMA HOLDINGS INC |
7992.0 kg |
310510
|
CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT |
2024-06-02 |
OOLU230221631001 |
RISING PHARMA HOLDINGS INC |
7636.0 kg |
310420
|
OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS |
2024-05-21 |
OOLU230219860001 |
RISING PHARMA HOLDINGS INC |
6983.0 kg |
310510
|
LORATADINE TABLETS USP 10 MG |
2024-05-18 |
MEDUJ7316121 |
RISING PHARMA HOLDINGS INC |
8153.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS TOTAL 39 PACKAGE S 1260 CARTONS ON 39 PAC KAGES (ONE THOUSAND TWO HUNDRED SIXTY CARTONS ON THIRTY NINE PACKAGES ONLY) SHIPMENT OF PHARMACEUT ICAL FINISHED FORMULATION AS PER ORDER NO.: 2049 46 (4500013805) 204955 ( 4500014 105) 204967 (4500 014142) 204948 (4500013 9 72) 204962 (4500014128) VENLAFAXINE ER TA BS 225 MG 30CT NDC 64980-581-03 - HTS 3004. 90.9235 HS CO DE NO.: 3004 90 99 GLIPI ZI DE EXTENDED-RELEASE TABL ETS 10MG 500CT ND C 6498 0-281-05 - HTS CODE 3004.9 0.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDE D-R ELEASE TABLETS 10MG 1,0 00CT NDC 64980-28 1-10 - HTS CODE 3004.90.9190 HS CODE NO.: 300 4 90 99 OXYBUTYNIN CHLORIDE EXTEND ED-RELEASETABLETS, USP 5M G 100CT NDC 64980-209-01 - HTS 3004.90.9190 HS CO DE NO.: 3004 90 99 OXYBU TYNIN CHLORIDE EXTENDED-RE LEASE TABLE TS, USP 5MG 500 CT NDC 64980-209-05 - HTS 30 04.90.9190 HS CODE NO .: 3004 90 99 DICLO FENAC SODIUM DELAYED-RELEASE TA BLETS, USP 75MG 100CT NDC 16571-201-10 - HTS 3004.9 0.912 0 HS CODE NO.: 3004 90 69 CUSTOMS INVOICE N O.: 1230627359 DT.27.0 3.2024 123062 7385 DT.28. 03.2024 1230627391 DT.28 .03.20 24 1230627392 DT.2 8.03.2024 COMMERCI AL INVOICE NO.: 90028471 DT.28.03.2024 90028472 DT.28.03.2024 SB NO: 8680377 DT.27 .03.2024 87 39352 DT.29.03.2024 874 0987 DT.29.03.2024 87394 12 DT.29.03.2024 THE TEM PERATURE TO BE SET AT 18 D EGREE CELCIUS IN ACCORDANC E WITH SHIPPER INSTRUCTION S |
2024-05-12 |
MEDUJ7232583 |
RISING PHARMA HOLDINGS INC |
7109.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 819 CARTONS ON 3 7 PACKAGES (EIGHT HUNDRE D NINETEEN CARTONS ON THIR TY SEVEN PACKAGES ONLY) S HIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PE R ORDER NO.: 204962 (45000 14128) 204952 (450001410 2) 204964 (4500014139) 204948 (4500013972) 204 961 (4500014127) 204944 (45000138 78) 204955 (450 0014105) 204967 (4500014 142)DICLOFENAC SODIUM D ELAYED-RELEASE TABLETS, US P 75MG 100CT NDC 16571-20 1-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CARBAMAZEPINEEXTENDED REL EASE TABLETS 200MG, 100CT NDC 1 6571-681-01-HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 OXYBUTYNIN CHLORIDE EXTENDED-RE LEASE TABLETS, USP 15MG 100CT N DC 64980-211- 01 - HTS 3004 .90.9190 HS CODE NO.: 30 04 90 99 OXYBUTYNIN CHLO RIDE EXTENDED-RELEASE TABLETS, USP 5MG 100CT NDC 6 4980-209-01 - HTS 3 004.90. 9190 HS CODE NO.: 3004 9 0 99 BLUE POINT - DICLOF ENAC SODIUM DELAYED-RELEAS E TABLETS, USP 75MG 500CT - NDC 68001-281-03 - HTS3 004.90.9120 HS CODE NO.: 3004 90 69 GLIPIZ IDE EX TENDED-RELEASE TABLETS 5MG 100CT NDC 6 4980-280-01 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 500CT NDC 6 4980-280-05 - HTS CODE 300 4.90.9190 HS CODE NO.: 3 004 90 99 CUSTOMSINVOIC E NO.: 1230627334 DT.26.03 .2024 1230 627339 DT.26.03. 2024 1230627335 DT.26.03.2 024 COMMERCIAL INVOICE NO. : 90028407 & 90028408 DT.2 6.03.2024 SB NO: 8646295 D T.26.03.20 24 8646305 DT.26 .03.2024 8646290 DT.26.03. 2024 NET. WT. 5,233.350 K GS TEMP : PLUS 18 DC# # MARCELLA.RODRIGUEZ=SAV INODELBENE.COM RI SINGPHA RMA.NY=SAVINODELBENE.COM CONTACT NO.:+1-718-906-2 732 THE TEMPERATURE TO BE SET A T +18 DEGREE CELCIU IN ACCORDANCE WITH SHIPPER INSTRUCTIONS |
2024-05-12 |
MEDUJ7269049 |
RISING PHARMA HOLDINGS INC |
6512.0 kg |
300490
|
768 CARTONS ON 41 PACKAGES (SEVEN HUNDRED SIXTY EI GHT CARTONS ON FORTY ONE P ACKAGES ONLY) SHIPMENT O F PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER N O.: 204946 (4500013805) 204948 (4500013972) 204967 (4500014142) VENLAFAXINE ER TABS 150 MG 30CT NDC 64980-580-03- HTS 3004.90. 9235 HS CODE NO.: 3004 9 0 99 VE NLAFAXINE ER TABS 150 MG 90CT NDC 64980-5 80-09- HTS 3004.90.9235 HS CODE NO.: 3004 90 99 VENLAFAXINE ER TABS 225 MG 30CT NDC 64980-581-03- HTS 3004.90.9235 HS CODE NO.: 3004 90 99OXYBUTY NIN CHLORIDE EXTENDED-RELE ASE TABLE TS, USP 5MG 100CT NDC 64980-209-01 - HTS 3 004.90.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EX TENDED-RELEASE TABLETS 10M G 500CT NDC 6498 0-281-05 - HTS CODE 3004.90.9190 HS CODE NO.:3004 90 99 GLIPIZIDE EXTENDED-RELEAS E TABLE TS 5MG 500CT NDC 64980-280-05 - HTS CODE 30 04.90.9190 HS CODE NO.: 3004 90 99 CUSTOMS INVOI CE NO. 1230627345 DT.26.0 3.2024 1230627347 DT.26.03 .2024 1230627354 DT.26.03. 2024 COMMERCIAL INVOICE NO . 90028412 & 90028413 DT .26.03.2024 SB NO. 864721 4 DT.27.03.2024 864 7112 DT .26.03.2024 8647118 DT.26. 03.2024 NET. WT. 4,596.620 KGS TEMP : PLUS 18 DC THE TEMPERATURE TO BE SE T AT +18 DEGREE CELCIUS INACCORDANCE WITH SHIPPER I NSTRUCTIONS ## MA RCELLA .RODRIGUEZ=SAVINODELBENE.C OM RISINGPHARMA.NY=SAVIN ODELBENE.COM CONTACT NO. : +1-718-906-2732 |
2024-05-12 |
MEDUJ7228037 |
RISING PHARMA HOLDINGS INC |
7875.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 1065 CAR TONS ON 40 PACKAGES (ONE THOUSAN D SIXTY FI VE CARTONS ON FORTY PACKAGES ONLY) SHI PM ENT OF PHARMACEUTICAL FINISHED FORMULATION ASPE R ORDER NO.: 204962 (450 0014128) 204 922 (4500013 678) 204944 (4500013878) 20495 5 (4500014105) D ICLOFENAC SODIUM DELAYED-R ELEASE TABLETS, USP 50MG 6 0CT NDC 16571-2 02-06 - H TS 3004.90.9120 HS CODE NO.: 3004 90 69 DICLOFEN AC SODIUM DELAYED-RELEASE T ABLETS, USP 50MG 100CT N DC 16571-202-10 - H TS 3004 .90.9120 HS CODE NO.: 30 04 90 69 DICLOFENAC SODI UM DELAYED-RELEASE TABLETS , USP 50MG 1,000CT NDC 16 571-202-11 - HTS 30 04.90.9 120 HS CODE NO.: 3004 90 69 DICLO FENAC SODIUM DE LAYED-RELEASE TABLETS, USP 75MG 60CT NDC 16571-201 -06 - HTS 3004.90.912 0 H S CODE NO.: 3004 90 69 G LIPIZIDE EXT ENDED-RELEASE TABLETS 5MG 500CT NDC 64 980- 280-05 - HTS CODE 3004 .90.9190 HS CODE NO. : 30 04 90 99 CUSTOMS INVOICE NO.: 123062 7316 DT.23.0 3.2024 1230627325 DT.23. 03.20 24 COMMERCIAL INVOI CE NO.: 90028396 DT.23. 03. 2024 NET. WT. 5,661.790 KGS TEMP : PL US 18 DC == INDIA. TEL: 30451397 /259 ## MARCELLA RODRI GUEZ MARCELLA.RODRIGUEZ= S AVINODELBENE.COM RISING PHARMA.NY=SAVINODEL BENE.CO M CONTACT NO.: +1-718-90 6-2732 T HE TEMPERATURE T O BE SET AT +18 DEGREE CEL CIUS IN ACCORDANCE WITH SH IPPER INSTRUCTIONS |
2024-05-08 |
HLCUBO1OCBHIK8AA |
RISING PHARMA HOLDINGS INC |
6035.0 kg |
300490
|
CETIRIZINE HYDROCHLORIDE TABLETS 1 X 40FT HC RF CONTAINER CONTAINS TOTAL 38 PACKAGES 438 CARTONS ON 38 PACKAGES (FOUR HUNDRED THIRTY EIGHT CARTONS ON THIRTY EIGHT PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO. 204953 (4500014103) 204935 (4500013873) CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 16571-402-50 - HTS 3004.90.9180 HS CODE NO. 3004 90 31 CETIRIZINE HYDROCHLORIDE TABLETS 5MG 100CT NDC 16571-401-10 - HTS 3004.90.9180 HS CODE NO. 3004 90 31 CUSTOMS INVOICE NO. 1230627364 DT.27.03.2024 COMMERCIAL INVOICE NO. 90028432 DT.27.03.2024 SB NO 8675129 DT.27.03.2024 NET WEIGHT 5023.060 KGS FREIGHT PREPAID |
2024-04-23 |
SULPTHN008129NYC |
RISING PHARMA HOLDINGS INC |
6203.0 kg |
300490
|
875 CARTONS ON 35 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204916 4500013656, 204948 4500013972 204952 4500014102, 204944 4500013878 204958 4500014109, 204959 4500014110 204955 4500014105, 204951 4500014101 204956 4500014106, 204957 4500014107 204968 4500014143 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, USP 10MG 100CT NDC 64980-210-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELE ASE TABLETS, USP 15MG 100CT NDC 64980-211-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, USP 10MG 500CT NDC 64980-201-05 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 CARBAMAZEPINE EX TENDED RELEASE TABLETS 100MG,100 CT NDC 16571-680-01- HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 GLIPIZIDE EXTENDED- RELEASE TABLETS10MG 1,000CT NDC 64980-281-10 - HTS CODE 300 4.90.9190 HS CODE NO.: 3004 90 99 TINIDAZOLE TABLETS 500MG 12CT NDC 64980-427-12 - HTS 3004.90.9110 HS CODE NO.: 3004 90 23 TOLTERODINETARTRATE TAB 2 MG 60 CT NDC 16571-127-06- HT S 3004.90.9265 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED- RELEASE TABLETS 10MG 500CT NDC 64980-281-05 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 BLUE POINT - MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25 MG 1000 CT NDC 68001-529-08 - HTS 3004.90.9280 HS CODE : 3004 90 39 LORATADINE TABLETS USP 10 MG 30CT NDC 16571-822-03 - HTS CODE 3004.90.9280 HS CODE N O.: 3004 90 39 MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25MG 100CT NDC 16571-824-01- HTS 3004.90.9280 HS CODE : 3004 90 39 LORATADINE TABLETS USP 10 MG 300CT NDC 16571-822-30 - HTSCODE 3004.90.9280 HS CODE NO.: 3004 90 39 CU STOMS INVOICE NO.: 1230627265 DT.21.03.2024 1230627266 DT.21.03.2024 1230627268 DT.21.03.2024 1230627270 DT.21.03.2024 NET WT: 4282.040 KGS |
2024-04-23 |
SULPTHN008125NYC |
RISING PHARMA HOLDINGS INC |
7641.0 kg |
300490
|
1065 CARTONS ON 41 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS 204919 4500013667 204935 4500013873 204953 4500014103 204965 4500014140 204962 4500014128 CETIRIZINE HYDROCHLORIDE TABLETS 5MG 100CT NDC 16571-401-10- HTS 3004.90.9180 HS CODE NO.:30049031 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 100CT NDC 16571-402-10- HTS 3004.90.9180 HS CODE NO.:3 0049031 CETIRIZINE HYDROCHLORIDE TABLETS 10MG500CT NDC 16571-402-50- HTS 3004.90.9180 HS CODE NO.:30049031 DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 75MG 1,000CT NDC 16571-201-11- HTS 3004.90.9120 HS CODE NO.:30049069 CUSTOMS INVOICE NO.: 1230627272 DT.21.03.2024 COMMERCIAL INVOICE NO.: 90028340 DT.21.03.202 4 NET WT: 5520.800 KGS |
2024-04-16 |
MEDUE7779550 |
PANAMEDICAL DE COSTA RICA S A |
10899.0 kg |
847439
|
IOHEXOL 64.7 PCT(IOHEXOL INJECTION USP300MG I/ML - 1X40FT HC CONTAINER CONTAI NING 551 C ARTONS (23 PAL LETS) DESCRIPTION OF GOODS AND/OR SERVICES + 55,000 IO HEXOL 64.7 PCT(IO HEXOL INJ ECTION USP300MG I/ML ACCO RDING TO PURCHASE ORDER P- 06-22.IIPER.(III DEL.) S HIPPING TERMS: CIF ANY POR T OF COSTA RICA, INCOTERMS 2020. CUSTOM INVOICE NO : 1230 627140 DT.29.02.2 024 COMMERCIAL INVOICE N O: 90028225 DT.29.02.20 24 SB.NO: 795624 6 DT.29. 02.2024 IRREVOCABLE DOCU MENTARY CREDIT NUMBER: LC-682/23 DATE OF ISSUE: 2 40227 REF: LC-682/23. FREIGHT PREPAID DOOR D ELIVERY ADDRESS: PANAMEDIC AL DE COSTA RICA, S.A. (O FIPLAZA DEL ESTE, EDIFICIO C, III PI SO, SAN JOSE, CO STA RICA, |
2024-04-08 |
MIPJMTRMUM240079 |
PHARMACEUTICAL TECHNOLOGY |
13460.0 kg |
300510
|
SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATI30049069 . . |
2024-04-04 |
MEDUE7622214 |
RISING PHARMA HOLDINGS INC |
7769.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 1083 CAR TONS ON 41 PACKAGES (ONE THOUSAN D EIGHTY T HREE CARTONS ON FORTY ONE PACKAGES ONLY) SHIPMENT OF PHARMACEUTICA L FINISHED FORMULATION AS PER ORDER NO.: 204905 (4 500013456) 20 4936 (45000 13874) 204944 (450001387 8) 2 04942 (4500013880) CETIRIZINE HYDROCHLORIDE T ABLETS 10MG 100CT NDC 1 6571-402-10 - HTS 3 004.90. 9180 HS CODE NO.: 3004 9 0 31 CIP ROFLOXACIN TABLE TS, UPS 500MG 500CT NDC 16 571-412-50 - HTS 3004.20 .0060 HS CODE NO.: 3004 20 13 GLIPIZIDE EXTENDED -RELEASE TAB LETS 5MG 100CT NDC 64980-280-01 - HTS CODE 3004.90.9190 HS COD E NO.: 3004 90 99 LORAT A DINE TABLETS USP 10 MG 100 CT NDC 16571-0 822-01 - H TS CODE 3004.90.9280 HS CODE NO. : 3004 90 39 CUS TOMS INVOICE NO.: 123062 7029 DT.19.02.2024 12306 27030 DT.19.02.20 24 COMM ERCIAL INVOICE NO.: 90028 122 DT.1 9.02.2024 NET. W T. 5,419.860 KGS TEMP : +18 DGREE. THE TEMPERAT URE TO BE SET AT + 18 DEGRE E CELCIUS IN ACCORDANCE WI TH SHIPPER INSTRUCTIONS == MARCELLA.RODRIGUEZ=SAVI NOD ELBENE.COM RISINGPHAR MA.NY=SAVINODELBENE.C OM CONTACT NO.: +1-718-906-27 32 |
2024-04-02 |
OOLU230175843001 |
RISING PHARMA HOLDINGS INC |
6513.0 kg |
291813
|
PHARMACEUTICAL TOLTERODINE TARTRATE TAB 2 MG 60 CT |
2024-04-02 |
CMDUAMC2179987 |
RISING PHARMA HOLDINGS INC |
6683.0 kg |
300490
|
------------ TTNU8668680 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 41 PACKAGES 771 CARTONS ON 41 PACKAGES (SEVEN HUNDRED SEVENTY-ONE CARTONS ON FORTY-OPACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATI PER ORDER NO.: 204946 (4500013805) 204944 (4500013878) VENLAFAXINE ER TABS 37.5 MG 30CT NDC 64980-578-03- HTS 3004.90.9235 HS CODE NO.: 3004 90 99 VENLAFAXINE ER TABS 37.5 MG 90CT NDC 64980-578-09- HTS 3004.90.9235 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 10MG 100CTNDC 64980-281-01 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 2.5MG 30CTNDC 64980-279-03 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 NET WEIGHT :4,386.980 KGS CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO.AMC2174573 FREIGHT COLLECT -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |
2024-04-02 |
CMDUAMC2179564 |
RISING PHARMA HOLDINGS INC |
7270.0 kg |
300490
|
------------ AMCU9333026 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 40 PACKAGES 855 CARTONS ON 40 PACKAGES (EIGHT HUNDRED FIFTY FIVE CARTONS ON FORTY PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATI PER ORDER NO.: 204944 (4500013878) 204963 (4500014138) 204934 (4500013872) GLIPIZIDE EXTENDED-RELEASE TABLETS 2.5MG 30CTNDC 64980-279-03 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 ATENOLOL TABLETS, USP 100MG 1,000CT NDC 64980-439-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 74 ATENOLOL TABLETS, USP 25MG 1,000CT NDC 64980-437-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 74 CUSTOMS INVOICE NO.: 1230627102 DT.28.02.2024 1230627103 DT.28.02.2024 COMMERCIAL INVOICE NO.: 90028190 DT.28.02.202SB NO: 7899896 /7897980 DT.28.02.2024 NET WT : 5,775.310 KGS FREIGHT COLLECT CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO.AMC2174610 -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER S THE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |
2024-04-02 |
CMDUAMC2180371 |
RISING PHARMA HOLDINGS INC |
7126.0 kg |
300490
|
------------ AMCU9335369 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 36 PACKAGES 845 CARTONS ON 36 PACKAGES (EIGHT HUNDRED FORTY-FIVE CARTONS ON THIRTY-SPACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATI PER ORDER NO.: 204940 (4500013882) 204945 (4500013877) 204955 (4500014105) OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS,10MG 100CT NDC 64980-210-01 - HTS 3004.90.919HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, 10MG 500CT NDC 64980-210-05 - HTS 3004.90.919HS CODE NO.: 3004 90 99 DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, US75MG 60CT NDC 16571-201-06 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 GLIPIZIDE EXTENDED-RELEASE TABLETS 10MG 100CTNDC 64980-281-01 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 NET WEIGHT : 4,991.010 KGS CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO AMC2174606 FREIGHT COLLECT -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |
2024-04-02 |
SULPTHN008035NYC |
RISING PHARMA HOLDINGS INC |
7856.0 kg |
300490
|
1105 CARTONS ON 41 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204940 4500013882 204945 4500013877 204905 4500013456 204938 4500013876 204944 4500013878 204963 4500014138 OXYBUTYNIN CHLORIDE EXTENDEDRELEASE TABLETS, USP 5MG 500CT NDC 6498020905 HTS 3004.90.9190 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDEDRELEASE TABLETS, USP 15MG 100CT NDC 6498021101 HTS 3004.90 .9190 HS CODE NO.: 3004 90 99 DICLOFENAC SODIUM DELAYEDRELEASE TABLETS, USP 25MG 100CT NDC1657120310 HTS 3004.90.9120 HS CODE NO.: 30 04 90 69 DICLOFENAC SODIUM DELAYEDRELEASE TABLETS, USP 50MG 100CT NDC 1657120210 HTS 3004 .90.9120 HS CODE NO.: 3004 90 69 CETIRIZINE H YDROCHLORIDE TABLETS 10MG 500CT NDC 1657140250 HTS 3004.90.9180 HS CODE NO.: 3004 90 31 B LUE POINT DICLOFENAC SODIUM DELAYEDRELEASE T ABLETS, USP 25MG 100CT NDC 6800127900 HTS 3 004.90.9120 HS CODE NO.: 3004 90 69 BLUE POINT DICLOFENAC SODIUM DELAYEDRELEASE TABLETS, USP 50MG 60CT NDC 6800128006 HTS 3004.90.91 20 HS CODE NO.: 3004 90 69 BLUE POINT DICLOF ENAC SODIUM DELAYEDRELEASE TABLETS, USP 50MG 100CT NDC 6800128000 HTS 3004.90.9120 HS CO DE NO.: 3004 90 69 BLUE POINT DICLOFENAC SOD IUM DELAYEDRELEASE TABLETS, USP 50MG 1,000CT NDC 6800128008 HTS 3004.90.9120 HS CODE NO. : 3004 90 69 GLIPIZIDE EXTENDED RELEASE TABLETS 10MG 1,000CT NDC 6498028110 HTS CODE 3004 .90.9190 HS CODE NO.: 3004 90 99 ATENOLOL TAB LETS 50MG 1,000CT NDC 6498043810 HTS 3004.90 .9120 HS CODE NO.: 3004 90 74 NET WT: 5938.600 KGS |
2024-04-02 |
SULPTHN008022NYC |
RISING PHARMA HOLDINGS INC |
8427.0 kg |
300420
|
1187 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204966 4500014141 204941 4500013881 204950 4500014100 204938 4500013876 204954 4500014104 204940 4500013882 CIPROFLOXACIN TABLETS, UPS 500MG 500CT NDC 16571-412-50 - HTS 3004.20.0060 HS CODE NO.: 3004 20 13 MIDODRINE HYDR OCHLORIDE TABLETS, USP 10MG 100 CT NDC 64980-435-01 - HTS CODE 3004.90.9220 HS CODE NO.: 3004 90 99 ATENOLOL TABLETS 50MG 1,000CT NDC 64980-438-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 74 BLUE POINT - DICLOFENAC SODIUM DELAYED- RELEASE TABLETS, USP 75MG 60CT - NDC 68001-281-06 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYE D- RELEASE TABLETS, USP 75MG 1,000CT - NDC 68001-281-08 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CIPROFLOXACIN TABLETS, USP 250MG 100CT NDC 16571-411-10 - HTS 3004.20.0060 HS CODE NO.: 3004 20 13 CIPROFLOXACIN TABLETS, USP 500MG 100CT NDC 16571-412-10 - HTS 3004.20.0060 HS CODE NO.: 3004 20 13 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, USP 5MG 100CT NDC 64980-209-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 CUSTOMS INVOICE NO.: 1230627075 D T.26.02.2024 1230627076 DT.26.02.2024 1230627077 DT.26.02.2024 COMMERCIAL INVOICE NO.: 90028166 DT.26.02.2024 90028167 DT.26.02.2024 SBNO: 7845942 ,7847291, 7847269 DT.26.02.2024 NET WT: 6474.110 KGS |
2024-04-02 |
SULPTHN008036NYC |
RISING PHARMA HOLDINGS INC |
7224.0 kg |
300490
|
633 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204919 4500013667 204905 4500013456 2049554500014105 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 16571-402-50 - HTS 3004.90.9180 HS CODE NO.: 3004 90 31 GLIPIZIDE EXTENDED-RELEASE TABLETS 10MG 500CT NDC 64980-281-05 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 NET WT: 5779.070 KGS |
2024-03-27 |
SULPTHN008010NYC |
RISING PHARMA HOLDINGS INC |
7573.0 kg |
300490
|
886 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204937 4500013875 204940 4500013882 2049054500013456 204934 4500013872 204950 45000141 00 204939 4500013884 CLOMIPRAMINE CAPS 50MG 30CT NDC 16571068403 HTS 3004.90.9235 HS CODE NO.: 3004 90 99 CLOMIPRAMINE CAPS 50MG 90CT N DC 16571068409 HTS 3004.90.9235 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED RELEASE TABLETS, USP 15MG 100CT NDC 6498021101 HT S 3004.90.9190 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED RELEASE TABLETS, USP 15MG 100CT NDC 6498021101 HTS 3004.90.9190 HS CODE NO.: 3004 90 99 CETIRIZINE HYDROCHLORID E TABLETS 10MG 500CT NDC 1657140250 HTS 3004 .90.9180 HS CODE NO.: 3004 90 31 ATENOLOL TABLETS 50MG 1,000CT NDC 6498043810 HTS 3004.90 .9120 HS CODE NO.: 3004 90 74 TOLTERODINE TARTRATE TAB 1 MG 60 CT NDC 1657112606 HTS 3004.90.9265 HS CODE NO.: 3004 90 99 CUSTOMS INVOICE NO.: 1230627042 DT.22.02.2024 1230627043 DT.22.02.2024 1230627044 DT.22.02.2024 1230627045 DT.22.02.2024 COMMERCIAL INVOICE NO.: 900 28142 DT.22.02.2024 90028143 DT.22.02.2024 NET WT: 5985.870 KGS |
2024-03-22 |
SULPTHN007989NYC |
RISING PHARMA HOLDINGS INC |
7871.0 kg |
300490
|
1066 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204936 4500013874 204942 4500013880 204943 4500013879 204944 4500013878 204940 4500013882 LORATADINE TABLETS USP 10 MG 300CT NDC 16571-0822-30 - HTS CODE 3004.90.9280 HS CODE NO.: 3004 90 39 LORATADINE TABLETS USP 10 MG 1 00CT NDC 16571-0822-01 - HTS CODE 3004.90.9280 HS CODE NO.: 3004 90 39 LORATADINE TABLETS USP 10 MG 30CT NDC 16571-0822-03 - HTS CODE 3004.90.9280 HS CODE NO.: 3004 90 39 LITHIUM CARBONATE EXTENDED- RELEASE TABLETS, USP 300MG500CT NDC 64980-205-05 - HTS 3004.90.9135 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED-RELE ASE TABLETS 10MG 100CT NDC 64980-281-01 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 CI PROFLOXACIN TABLETS, UPS 500MG 500CT NDC 16571-412-50 - HTS 3004.20.0060 HS CODE NO.: 300420 13 OXYBUTYNIN CHLORIDE EXTENDED- RELEASE TABLETS, USP 15MG 100CT NDC 64980-211-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 CUSTOMS INVOICE NO.: 1230627012 DT 15.02.2024, 1230627015 DT 15.02.2024, 1230627014 DT 15.02.202 4, 1230627013 DT 15.02.2024 COMMERCIAL INVOICE NO.: 90028112 DT: 15.02.2024 90028113 DT: 15.02.2024 NET WT: 5648.750 KGS |
2024-03-22 |
OOLU230165533001 |
RISING PHARMA HOLDINGS INC |
7675.0 kg |
300510
|
PHARMACEUTICAL FINISHED FORMULATION CETIRIZINE HYDROCHLORIDE |
2024-03-22 |
OOLU230165537001 |
RISING PHARMA HOLDINGS INC |
8358.0 kg |
280511
|
DICLOFENAC SODIUM DR TAB 75MG |
2024-03-05 |
SULPTHN007929NYC |
RISING PHARMA HOLDINGS INC |
6639.0 kg |
300490
|
736 CARTONS ON 39 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204922 4500013678 GLIPIZIDE EXTENDED- RELEASE TABLETS 5MG 100CT NDC 64980-280-01 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED- RELEASE TABLETS 2.5MG 30CT NDC 64980-279-03 - HTS CODE 3004.90.9190 HS CO DE NO.: 3004 90 99 GLIPIZIDE EXTENDED- RELEASE TABLETS 5MG 500CT NDC 64980-280-05 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 CUSTOMS INVOICE NO.: 1230626977 DT.31.01.2024 COMMERCIAL INVOICE NO.: 90028063 DT.31.01.2024 NET WT: 4454.840 KGS |
2024-03-05 |
SULPTHN007931NYC |
RISING PHARMA HOLDINGS INC |
6261.0 kg |
300490
|
523 CARTONS ON 34 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204917 4500013657 204862 4500013047 2049054500013456 ATENOLOL TABLETS, USP 25MG 1,000C T NDC 64980-437-10 - HTS 3004.90.9120 HS CODENO.: 3004 90 74 CETIRIZINE HYDROCHLORIDE TAB LETS 10MG 500CT NDC 16571-402-50 - HTS 3004.9 0.9180 HS CODE NO.: 3004 90 31 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 100CT NDC 16571-402-10 - HTS 3004.90.9180 HS CODE NO.: 3004 90 31 CUSTOMS INVOICE NO.: 1230626937 DT.31.01.2024COMMERCIAL INVOICE NO.: 90028032 DT.31.01.20 24 SB NO: 7171842 DT.31.01.2024 NET WT: 4983.510 KGS |
2024-03-05 |
SULPTHN007930NYC |
RISING PHARMA HOLDINGS INC |
8253.0 kg |
300490
|
1166 CARTONS ON 39 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204927 4500013687 204917 4500013657 204879 4500013114 204918 4500013658 DICLOFENAC SODIUM DELAYED- RELEASE TABLETS, USP 75MG 60CT NDC 16571-201-06 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 DICLOFENAC SODIUM DELAYED- RELE ASE TABLETS, USP 50MG 1,000CT NDC 16571-202-11 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 DICLOFENAC SODIUM DELAYED- RELEASE TABLETS, USP 50MG 100CT NDC 16571-202-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 ATENOLOL TABLETS50MG 1,000CT NDC 64980-438-10 - HTS 3004.90. 9120 HS CODE NO.: 3004 90 74 DOXEPIN HYDROCHLORIDE CAPSULES 10MG 100CT NDC 64980-059-401 - HTS 3004.90.9236 HS CODE NO.: 3004 90 99 DOX EPIN HYDROCHLORIDE CAPSULES 50MG 100CT NDC 64980-059-601 - HTS 3004.90.9236 HS CODE NO.: 3004 90 99 CARBAMAZEPINE EXTENDED RELEASE TABLETS 400MG,100CT NDC 16571-682-01- HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 CUSTOMS INVOICE NO.: 1230626895 DT.30.01.2024 1230626896 DT.30.01.2024 COMMERCIAL INVOICE NO.: 90028 014 DT.30.01.2024 NET WT: 6256.500 KGS |
2024-03-05 |
OOLU230157615001 |
RISING PHARMA HOLDINGS INC |
5178.0 kg |
300510
|
PHARMACEUTICAL CETIRIZINE HYDROCHLORIDE |
2024-03-05 |
OOLU230157618001 |
RISING PHARMA HOLDINGS INC |
7473.0 kg |
310420
|
PHARMACEUTICAL OXYBUTYNIN CHLORIDE |
2024-02-23 |
SULPTHN007868NYC |
RISING PHARMA HOLDINGS INC |
7716.0 kg |
300490
|
1000 CARTONS ON 39 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204897 4500013460 204922 4500013678 204927 4500013687 GLIPIZIDE EXTENDEDRELEASE TABLETS 5MG 100CT NDC 6498028001 HTS CODE 3004.90. 9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDEDRELEASE TABLETS 5MG 500CT NDC 6498028005 H TS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 DICLOFENAC SODIUM DELAYED RELEASE TABLETS, USP 75MG 60CT NDC 1657120106 HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CUSTOMS INVOICE NO.: 1230626823 DT.20.01.2024 1230626825 DT.20.01.2024 COMMERCIAL INVOICE NO.: 90027950 DT.20.01.2024 NET WT: 5500.840 KGS TEMPERATURE TO BESET AT 18.0 C |
2024-02-23 |
SULPTHN007871NYC |
RISING PHARMA HOLDINGS INC |
8614.0 kg |
300490
|
1254 CARTONS ON 41 PACKAGES ONE THOUSAND TWO HUNDRED FIFTY FOUR CARTONS ON FORTY ONE PACKAGES ONLY SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204921 4500013671 204927 4500013687 204917 4500013657 CLOMIPRAMINE CAPS 25MG 30CT NDC 16571-068-303-HTS 3004.90.9235 HS CODE NO.: 3004 90 99 CLOMIPRAM INE CAPS 25MG 90CT NDC 16571-068-309-HTS 3004.90.9235 HS CODE NO.: 3004 90 99 DICLOFENAC SODIUM DELAYED- RELEASE TABLETS, USP 75MG 60CTNDC 16571-201-06- HTS 3004.90.9120 HS CODE N O.: 3004 90 69 ATENOLOL TABLETS 50MG 1,000CT NDC 64980-438-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 74 NET WT: 6294.520 KGS TEMPERATURE TO BE SET AT 18.0 C |
2024-02-15 |
CMDUAMC2154150 |
RISING PHARMA HOLDINGS INC |
7103.0 kg |
300490
|
------------ BEAU9700872 DESCRIPTION---------30049069 (HS) 1 X 40FT HC RF CONTAINER CONTAINS 1218 CARTONS ON 40 PACKAGES (ONE THOUSAND TWO HUNDRED EIGHTEEN CARTONS ON FORTY PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204905 (4500013456) 204925 (4500013686) 204920 (4500013669) 204927 (4500013687) 204883 (4500013168) CETIRIZINE HYDROCHLORIDE TABLETS 5MG 100CT NDC 16571-401-10 - HTS 3004.90.9180 HS CODE NO.: 3004 90 31 BLUE POINT - DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 25MG 100CT - NDC 68001-279-00 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CIPROFLOXACIN TABLETS, UPS 500MG 500CT NDC 16571-412-50 - HTS 3004.20.0060 HS CODE NO.: 3004 20 13 DICLOFENAC SODIUM DELAYED -RELEASE TABLETS, USP 25MG 100CT NDC 16571-203-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 NET WEIGHT : 5,378.340 KGS MUMBAI 400 059. CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO. AMC2152905 FREIGHT COLLECT TOTAL PKGS 1218 PK -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER SAT THE SHIPPER S REQUESTED CARRYING TEMPERATUOF 18 DEGREES CELSIUS |
2024-02-11 |
MEDUJ6618246 |
RISING PHARMA HOLDINGS INC |
4741.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS TOTAL 40 PACKAGE S 607 CARTONS ON 40 PACK AGES (SIX HUNDRED SEVEN CARTONS ON FORTY PACKAGES ONLY) SHIPMENT OF PHAR MACEUTICAL FINISHED FORMUL ATION AS PER ORDER NO.: 204894 (4500013392) 20 4902 (4500013467) 204827 (4500012732) 204881 (45 00013177) 204924 (450001 3681) 204894 (450 0013392 ) TOLTERODINE TARTRATE T AB 2 MG 60 CT NDC 16571- 127-06- HTS 3004.90.9265 HS CODENO.: 3004 90 99 TOLTERODINE TARTRATE TAB 1 M G 60 CT NDC 16571-126 -06- HTS 3004.90.9265 HS CODE NO.: 3004 90 99 SB N O: 6345308 DT.27.12.2023 6 345614 DT.27.12.2023 THE T EMPERATURE TO BE SET AT +1 8 DEGREE CELCIUS IN ACCORDANCE WITH SHIPPER INSTRUCT IONS |
2024-02-11 |
MEDUJ6634573 |
RISING PHARMA HOLDINGS INC |
7628.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS TOTAL 41 PACKAGE S 1168 CARTONS ON 41 PAC KAGES (ONE THOUSAND ONE HUNDRED SIXTY EIGHT CARTO NS ON FORTY ONE PACKAGES O NLY) SHIPMENT OF PHARMA CEUTICAL FINISHED FORMULAT ION AS PER ORDER NO.: 204923 (4500013680) 2049 25 (4500013686) LORATADI NE TABLETS USP 10 MG 300CT NDC 16571-0 822-30 - HTS CODE 3004.90.9280 HS CO DE NO.: 3004 90 39 LORAT ADINE TABLETS USP 10 MG 10 0CT NDC 16571-0822-01 - HTS CODE 3004.90.9280 HS CODE NO.: 3004 90 39 BL UE POINT - DICLOFENAC SODI UM DELAYED-RELEASE TABLETS , USP 50MG 60CT - NDC 6800 1-280-06 - HTS 3004.90.912 0 HS CODE NO.: 3004 90 6 9 BLUE POINT - DICLOFENA C SODIUM DELAYED-RELEASE T ABLETS, USP 7 5MG 100CT - N DC 68001-281-00 - HTS 3004 .90.9120 HS CODE NO.: 30 04 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYED-RE LEASE TABLETS, US P 75MG 50 0CT - NDC 68001-281-03 - H TS 3004.90.9120 HS CODE NO.: 3004 90 69 CUSTOMS INVOICE NO.: 1230626753 DT .29.12.2023 SB NO: 64051 02 DATE: 29.12.2023 COMM ERCIAL INVOICE NO.: 900278 36 DT.29.12.2023 THE TE MPERATURE TO BE SET AT +18 DEGREE CELCIUS IN ACCORDA NCE WITH SHIPPER INSTRUCTI ONS |